GT
SRGA

Glenmede Trust’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Glenmede Trust’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed – – 2689
2020
Q1 		$0 Hold
5
– – ﹤0.01% 3085
2019
Q4 		$0 Hold
5
– – ﹤0.01% 3171
2019
Q3 		$0 Hold
5
– – ﹤0.01% 3165
2019
Q2 		$0 Buy
+5
New +$720 ﹤0.01% 3227
2016
Q2 		– Sell
-8
Closed – – 2751
2016
Q1 		$0 Hold
8
– – ﹤0.01% 2751
2015
Q4 		$0 Hold
8
– – ﹤0.01% 2805
2015
Q3 		$1K Buy
+8
New +$1.53K ﹤0.01% 2640

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Glenmede Trust's SRGA Position: Q2 2020 in Review

Glenmede Trust sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2020, closing a stake of 5 shares.

Glenmede Trust first reported a position in SRGA in Q3 2015 and held it in 7 quarters. The position peaked at $1K in Q3 2015. 88 funds tracked by Wall St. Rank hold SRGA as of Q2 2020.

  • Glenmede Trust reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 5 Surgalign Holdings, Inc. Common Stock shares in Q2 2020.
  • Glenmede Trust first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2015 and held it in 7 quarters.
  • Glenmede Trust's Surgalign Holdings, Inc. Common Stock position peaked at $1K in Q3 2015.
  • 88 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.